Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'24
Mar'23
Net Sales
697.27
29.11
Other Operating Income
0.00
0.00
Total Operating income
697.27
29.11
Raw Material Cost
196.80
12.32
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
Employee Cost
155.77
26.01
Power Cost
0.00
0.00
Manufacturing Expenses
0.07
0.06
Selling and Distribution Expenses
59.34
20.53
Other Expenses
18.16
10.65
Total Expenditure (Excl Depreciation)
593.63
165.43
Operating Profit (PBDIT) excl Other Income
103.6
-136.3
Other Income
15.57
4.50
Operating Profit (PBDIT)
120.90
-130.79
Interest
0.07
0.06
Exceptional Items
-170.78
-776.21
Gross Profit (PBDT)
500.47
16.80
Depreciation
1.68
1.02
Profit Before Tax
-51.64
-908.09
Tax
20.11
0.00
Provisions and contingencies
0.00
0.00
Profit After Tax
-71.74
-908.09
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
-71.74
-908.09
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
-71.74
-908.09
Equity Capital
0.00
0.00
Face Value
0.0
0.0
Reserves
-1,168.29
0.00
Earnings per share (EPS)
-0.86
-10.92
Diluted Earnings per share
-0.86
-10.92
Operating Profit Margin (Excl OI)
14.86%
-468.21%
Gross Profit Margin
-7.16%
-3115.48%
PAT Margin
-10.29%
-3118.98%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Analysis not available
Compare Quarterly Results Of Duality Biotherapeutics, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(HKD)
Change(%)
Net Sales
697.27
0
697.27
Other Operating Income
0.00
0.00
0.00
Total Operating income
697.27
0
697.27
Raw Material Cost
196.80
0
196.80
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
155.77
0
155.77
Power Cost
0
0
0.00
Manufacturing Expenses
0.07
0
0.07
Selling and Distribution Expenses
59.34
0
59.34
Other Expenses
18.16
0.00
18.16
Total Expenditure (Excl Depreciation)
593.63
0
593.63
Operating Profit (PBDIT) excl Other Income
103.65
0.00
103.65
Other Income
15.57
0
15.57
Operating Profit (PBDIT)
120.90
0
120.90
Interest
0.07
0
0.07
Exceptional Items
-170.78
0
-170.78
Gross Profit (PBDT)
500.47
0
500.47
Depreciation
1.68
0
1.68
Profit Before Tax
-51.64
0
-51.64
Tax
20.11
0
20.11
Provisions and contingencies
0
0
0.00
Profit After Tax
-71.74
0
-71.74
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-71.74
0
-71.74
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-71.74
0
-71.74
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
-1,168.29
0
-1,168.29
Earnings per share (EPS)
-0.86
0
-0.86
Diluted Earnings per share
-0.86
0
-0.86
Operating Profit Margin (Excl OI)
14.86%
0%
0.00
14.86%
Gross Profit Margin
-7.16%
0%
0.00
-7.16%
PAT Margin
-10.29%
0%
0.00
-10.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in Figures in Million
Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in Figures in Million
Quarterly - Interest
Interest NA Million
in Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in Figures in %






